BCAB: BioAtla, Inc. Stock

by  •  • Comments Off on BCAB: BioAtla, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 25.00
Enterprise Value ($M) -7.37
Book Value ($M) 0.55
Book Value / Share 0.01
Price / Book 45.70
NCAV ($M) -0.21
NCAV / Share -0.00
Price / NCAV -121.34

Profitability (mra)
Return on Invested Capital (ROIC) -56.20
Return on Assets (ROA) -0.69
Return on Equity (ROE) -1.24

Liquidity (mrq)
Quick Ratio 2.35
Current Ratio 2.35

Balance Sheet (mrq) ($M)
Current Assets 37.54
Assets 38.29
Liabilities 37.74
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 11.00
Operating Income -73.94
Net Income -69.78
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted Distributed n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -71.94
Cash from Investing 0.00
Cash from Financing 9.51

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-25 13G/A Highbridge Capital Management Llc 7.70 -34.15
03-18 13G OPOKA INVESTMENT FUND Co 6.10
02-07 13G/A Short Jay M Phd 6.60 11.78
01-24 13G/A Millennium Management Llc 1.90 -54.63
11-14 13G/A Tang Capital Management Llc 1.80
10-02 13D/A Soleus Private Equity Fund I, L.P. 2.56 -53.26
07-08 13G/A BlackRock, Inc. 1.60 -72.55

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2025-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 124,863 373,876 33.40
2025-05-08 186,989 523,342 35.73
2025-05-07 95,273 329,610 28.90
2025-05-06 251,743 673,526 37.38
2025-05-05 232,066 536,509 43.25

(click for more detail)

Similar Companies
AVBP – ArriVent BioPharma, Inc. AVDL – Avadel Pharmaceuticals plc
AXSM – Axsome Therapeutics, Inc. BHST – BioHarvest Sciences Inc.
BTMD – biote Corp.


Financial data and stock pages provided by
Fintel.io